GR3017580T3 - Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress. - Google Patents

Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress.

Info

Publication number
GR3017580T3
GR3017580T3 GR950402691T GR950402691T GR3017580T3 GR 3017580 T3 GR3017580 T3 GR 3017580T3 GR 950402691 T GR950402691 T GR 950402691T GR 950402691 T GR950402691 T GR 950402691T GR 3017580 T3 GR3017580 T3 GR 3017580T3
Authority
GR
Greece
Prior art keywords
pharmaceutical compositions
gastrointestinal tract
upper gastrointestinal
treating upper
ingestible pharmaceutical
Prior art date
Application number
GR950402691T
Other languages
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of GR3017580T3 publication Critical patent/GR3017580T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR950402691T 1991-04-04 1995-09-29 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress. GR3017580T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04
PCT/US1992/001981 WO1992017164A1 (en) 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress

Publications (1)

Publication Number Publication Date
GR3017580T3 true GR3017580T3 (en) 1995-12-31

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402691T GR3017580T3 (en) 1991-04-04 1995-09-29 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress.

Country Status (16)

Country Link
EP (1) EP0578768B1 (el)
JP (1) JPH06506682A (el)
KR (1) KR100238565B1 (el)
AT (1) ATE128351T1 (el)
AU (1) AU665349B2 (el)
BR (1) BR9205827A (el)
CA (1) CA2106215C (el)
CZ (1) CZ282105B6 (el)
DE (1) DE69205158T2 (el)
DK (1) DK0578768T3 (el)
ES (1) ES2077417T3 (el)
GR (1) GR3017580T3 (el)
HU (1) HU213203B (el)
RU (1) RU2126249C1 (el)
SK (1) SK121293A3 (el)
WO (1) WO1992017164A1 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2146637C (en) * 1992-10-09 2001-02-13 James Grigg Upson Pharmaceutical compositions and methods for treating cold symptoms
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
FI955144L (fi) * 1993-04-30 1995-10-31 Procter & Gamble Päällystetyt farmaseuttiset koostumukset
EP0698393B1 (en) * 1993-05-19 2002-07-03 Hisamitsu Pharmaceutical Co., Inc. 3-l-MENTHOXY-PROPANE-1, 2-DIOL AS SOLUBILIZING AGENT AND EXTERNAL PREPARATION CONTAINING THE SAME
CA2169735A1 (en) * 1993-08-17 1995-02-23 Henry C. Caldwell Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
JPH09504293A (ja) * 1993-10-28 1997-04-28 ザ、プロクター、エンド、ギャンブル、カンパニー マグネシウムアルミニウムシリケート及び複数の活性成分を含有した速溶解性剤形
BR9507199A (pt) * 1994-03-24 1997-09-09 Procter & Gamble Cellulose Formas de dose sólidas contendo bismuto
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
CO4410201A1 (es) * 1994-07-20 1997-01-09 Colgate Palmolive Co Metodos y composiciones farmaceuticas para el tratamiento de transtornos gastricos
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US6627233B1 (en) 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
RU2192251C1 (ru) * 2001-05-25 2002-11-10 Дальневосточный государственный медицинский университет Способ снижения гликемии у больных сахарным диабетом ii типа с гастродуоденальными язвами
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
RU2257890C2 (ru) * 2003-10-06 2005-08-10 Марио Атилио Лос Способ получения устойчивых фармацевтических композиций в форме таблеток, содержащих омепразол, и фармацевтические композиции, полученные таким способом
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル

Also Published As

Publication number Publication date
CA2106215A1 (en) 1992-10-05
RU2126249C1 (ru) 1999-02-20
DE69205158D1 (de) 1995-11-02
CZ282105B6 (cs) 1997-05-14
HUT65881A (en) 1994-07-28
KR100238565B1 (ko) 2000-02-01
DK0578768T3 (da) 1996-02-05
CA2106215C (en) 1997-05-27
EP0578768A1 (en) 1994-01-19
AU665349B2 (en) 1996-01-04
DE69205158T2 (de) 1996-04-18
CZ226093A3 (en) 1994-04-13
JPH06506682A (ja) 1994-07-28
HU213203B (en) 1997-03-28
AU1761492A (en) 1992-11-02
HU9302970D0 (en) 1994-01-28
ATE128351T1 (de) 1995-10-15
ES2077417T3 (es) 1995-11-16
WO1992017164A1 (en) 1992-10-15
BR9205827A (pt) 1994-06-28
SK121293A3 (en) 1994-07-06
EP0578768B1 (en) 1995-09-27

Similar Documents

Publication Publication Date Title
GR3017580T3 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress.
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
DE122007000022I2 (de) Pharmazeutische zusammensetzungen, welche ausgewählte lanthancarbonathydrate enthalten
TR200001810A3 (tr) Hemen Eriyen Oral Dozaj Formülasyonu.
IE862554L (en) Pharmaceutical compositions
EP0494972A4 (en) Effervescent dosage form and method of administering same
DK0636364T3 (da) Hurtigt desintegrerende farmaceutisk doseringsform og fremgangsmåde til fremstilling deraf
IT1229568B (it) Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
NO902280D0 (no) Ny poroes farmasoeytisk form og fremstilling derav.
GB2259647B (en) Medicaments for treating gastrointestinal disorders
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ITMI911998A1 (it) Dispositivo abradente agglomerato particolarmente per burattatura e simili nonche' procedimento realizzativo.
ATE157250T1 (de) Wismutsubsalicylat in form einer einheitsdosis
Ahmed et al. Acute gastric dilatation following upper gastrointestinal endoscopy
IT1259140B (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
IT8821437A0 (it) Procedimento per prolungare la permanenza nel tratto gastrointestinale di farmaci in formulazioni ad effetto prolungato e forme di dosaggio cosi' ottenute.
ES2094093B1 (es) Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.
AR034993A1 (es) Medicamento para la prevencion de la acidosis clinica y subclinica en animales policavitarios y/o rumiantes
ITMI20010971A0 (it) Formulazioni farmaceutiche e/o dietetiche contenenti colostro e uso del colostro per il trattamento dell'acne